Allergan Issues Nationwide Voluntary Recall of TAYTULLA® Softgel Capsules 1mg/20mcg Sample Packs Due to Out of Sequence Capsules
If your email program has trouble displaying this email, view it as a web page |
U.S. Food and Drug Administration |
If your email program has trouble displaying this email, view it as a web page |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
U.S. Food and Drug Administration |
Comments
Post a Comment